D.E. Shaw & Co
HRMY icon

D.E. Shaw & Co’s Harmony Biosciences HRMY Stock Holding History

D.E. Shaw & Co’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Sell
101,427
-12,883
-11% -$422K ﹤0.01% 2637
2025
Q4 		$4.28M Sell
114,310
-78,317
-41% -$2.58M ﹤0.01% 2440
2025
Q3 		$5.31M Sell
192,627
-60,354
-24% -$2.08M ﹤0.01% 2165
2025
Q2 		$7.99M Sell
252,981
-66,723
-21% -$2.15M 0.01% 1671
2025
Q1 		$10.6M Sell
319,704
-160,901
-33% -$5.77M 0.01% 1342
2024
Q4 		$16.5M Buy
480,605
+124,656
+35% +$4.28M 0.01% 1154
2024
Q3 		$14.2M Buy
355,949
+45,945
+15% +$1.61M 0.01% 1203
2024
Q2 		$9.35M Buy
310,004
+30,569
+11% +$919K 0.01% 1378
2024
Q1 		$9.38M Sell
279,435
-2,321
-0.8% -$74.5K 0.01% 1405
2023
Q4 		$9.1M Buy
281,756
+13,943
+5% +$389K 0.01% 1433
2023
Q3 		$8.78M Buy
267,813
+27,352
+11% +$950K 0.01% 1377
2023
Q2 		$8.46M Buy
240,461
+45,975
+24% +$1.59M 0.01% 1478
2023
Q1 		$6.35M Sell
194,486
-29,485
-13% -$1.34M 0.01% 1746
2022
Q4 		$12.3M Buy
223,971
+177,772
+385% +$9.77M 0.01% 1262
2022
Q3 		$2.05M Buy
46,199
+9,423
+26% +$460K ﹤0.01% 2985
2022
Q2 		$1.79M Buy
36,776
+8,317
+29% +$374K ﹤0.01% 3163
2022
Q1 		$1.39M Buy
+28,459
New +$1.16M ﹤0.01% 3638
2021
Q3 		– Sell
-44,765
Closed -$1.26M – 5067
2021
Q2 		$1.26M Buy
+44,765
New +$1.34M ﹤0.01% 3354

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co's HRMY Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Harmony Biosciences (HRMY) stake by 11% in Q1 2026, selling an estimated $422K and leaving 101,427 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

D.E. Shaw & Co first reported a position in HRMY in Q2 2021 and has held it in 18 quarters since. The position peaked at $16.5M in Q4 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • D.E. Shaw & Co held 101,427 shares of Harmony Biosciences worth $2.84M as of Q1 2026.
  • D.E. Shaw & Co sold 12,883 Harmony Biosciences shares in Q1 2026, an estimated $422K.
  • Harmony Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2637 holding.
  • D.E. Shaw & Co first reported a position in Harmony Biosciences in Q2 2021 and has held it in 18 quarters since.
  • D.E. Shaw & Co's Harmony Biosciences position peaked at $16.5M in Q4 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.